Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...
Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...
Investors watching the global biotech race may be sensing a shift after Moderna (NASDAQ:MRNA) co-founder and chairman Noubar ...
The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...
Amid profit forecast reductions, Pfizer is implementing a $7.7bn cost-cutting strategy, while investing into its ...
The FDA probe is more extensive than previously understood, as it encompasses both adult and pediatric cases. "FDA is doing a thorough investigation, across multiple age groups, of deaths potentially ...
Health IT’s Legacy and the Road to Responsible AI by Dr. S. Yin Ho is an indispensable book about the current state of health information technology and how responsible AI could reshape our U.S.
The Food and Drug Administration is investigating whether COVID-19 vaccines caused deaths in adults, as part of a safety ...
Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that ...
Pharmaceutical Technology on MSN
Moderna signs deal worth up to $503m with Nanexa
Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent ...
Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced a research program under its strategic collaboration with Pfizer whereby Flagship-founded ...
The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results